Date(s) - September 13,2019 - September 15,2019
8:00 am - 1:00 pm
Bally's Las Vegas
HOTEL INFO: please call us to assist with room reservation
Bally’s Las Vegas
Dr. Renee Jones, Pharm D.
Nova Southeastern University
Renee Greaves currently serves as the Director of Preceptor Development as Assistant Professor at Nova Southeastern University in Ft. Lauderdale, Florida. She has served as the Pharmacy Operations Supervisor and Residency Coordinator of Broward Health, where she implemented clinical pharmacy programs such as HIV and antibiotic stewardships, hepatic monitoring, cardiopulmonary discharge counseling, and internal medicine clinical rounds with graduate medical education residents. She has also served as a Clinical Assistant Professor of Rutgers University School of Pharmacy where she taught didactic courses such as Infectious Disease Therapeutics and numerous electives.
Friday September 13, 2019
ACPE # 0043-9999-19-026-L01-P
1. Discuss the clinical indications for the new medications approved by the FDA.
2. Explain the various mechanisms of action for the medications discussed within this program.
3. Recognize the clinically relevant drug interactions for the medications.
4. Identify the most common adverse reactions for the new drug approvals.
5. Explain the approved dosing guidelines and recommended dosage adjustments for the medications reviewed.
Dr. Stan Louie, Pharm D.
University of Southern California
Dr. Stan Louie received his Doctorate in Pharmacy from the University of California in San Francisco. He continued his postgraduate work at Pacific Presbyterian Medical Center in San Francisco where he was a pharmacy resident. In addition to clinical training, he continued his basic science training at the Kuzell Institute, where he served as Associate of Research in Molecular Biology. Following his training at Kuzell, he joined USC where he continued his work on cytokine regulation in relation to tumor and/or viral proliferation at the Kenneth Norris Cancer Research Institute. Presently, he is an Associate Professor at the University of Southern California School of Pharmacy and the Keck School of Medicine, where he is concentrating his work on virally-linked diseases, which include HIV and hepatitis B & C. In addition, he continues his efforts in drug discovery and development for the treatment of specific brain cancers and multiple myeloma.
ACPE # TBA
1. Review and identify the mechanisms of HIV infection and targets for pharmacotherapy.
2. Compare and contrast mechanisms of action of various antiretroviral agents.
3. Identify both clinical and laboratory values advocating the initiation of antiretroviral therapy.
4. Identify new agents in the fight against HIV and how they fit into the currently available agents.
5. Understand the antiviral effects associated with high active antiretroviral therapy (HAART).
6. Identify and manage possible drug-drug interactions between antiretroviral agents with other pharmacotherapeutic agents.
7. Understand and be able to manage various adverse effects associated with antiretroviral agents.
1. Recognize the mechanism of injury induced by radiation.
2. Determine the window of opportunity for radiation-induced injuries (e.g. GI, hematologic, and cutaneous injuries).
3. Be able to manage the efficacy and adverse effects associated with new mitigation agents.
4. Recognize the different clinical manifestations of various infectious agents (e.g bacteria, viruses, and biotoxins).
5. Develop pharmaceutical care strategies to reduce the adverse events of both the injuries and drug therapy.